Author: GarcÃa-Salido, Alberto
Title: Narrative review of the immune response against coronavirus: An overview, applicability for SARS-COV-2, and therapeutic implications() Cord-id: 327uvz3k Document date: 2020_6_8
ID: 327uvz3k
Snippet: The new coronavirus (SARS-CoV-2) that causes a severe acute respiratory syndrome emerges in Wuhan, China, in December 2019. It produces the aforementioned disease due to coronavirus 2019 (COVID-19), and has led to a declaration of a world public health emergency by the World Health Organisation. This new SARS-CoV-2 virus could share characteristics and an immune response similar to those described for other coronavirus. Given its activity on the interferon pathway, and the manner in which it dys
Document: The new coronavirus (SARS-CoV-2) that causes a severe acute respiratory syndrome emerges in Wuhan, China, in December 2019. It produces the aforementioned disease due to coronavirus 2019 (COVID-19), and has led to a declaration of a world public health emergency by the World Health Organisation. This new SARS-CoV-2 virus could share characteristics and an immune response similar to those described for other coronavirus. Given its activity on the interferon pathway, and the manner in which it dysregulates innate immunity, the use of treatments directed at modulating or containing this could be of interest. A narrative review was made of the current evidence about immunity against coronavirus and its applicability to SARS-CoV-2. The physiopathogenesis is also described, along with the underlying leucocyte activity, with the intention of clarifying the possible usefulness of inflammatory biomarkers and the development of personalised treatments.
Search related documents:
Co phrase search for related documents- accessory protein and acute pneumonia respiratory distress syndrome: 1
- accessory protein and acute sars respiratory distress syndrome: 1
- acute pneumonia and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8
- acute pneumonia and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- acute pneumonia and adaptive innate immunity: 1, 2
- acute pneumonia and additional feature: 1
- acute pneumonia and adequate sensitivity: 1
- acute pneumonia and adjuvant treatment: 1, 2, 3, 4, 5
- acute pneumonia and long duration: 1
- acute pneumonia and low number: 1, 2
- acute pneumonia respiratory distress syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6
- acute pneumonia respiratory distress syndrome and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- acute pneumonia respiratory distress syndrome and adaptive innate immunity: 1, 2
- acute pneumonia respiratory distress syndrome and adjuvant treatment: 1, 2, 3
- acute pneumonia respiratory distress syndrome and low number: 1
- acute pneumonia respiratory distress syndrome include and adaptive innate: 1
- acute pneumonia respiratory distress syndrome include and adaptive innate immunity: 1
- acute sars respiratory distress syndrome and adaptive immune response: 1, 2, 3
- acute sars respiratory distress syndrome and adaptive innate: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date